Ultragenyx (RARE) outlook: rare-disease pipeline with 2026–2027 catalysts (GTX-102, DTX401, UX111) and $1.5B–$2.4B peak sales ...

Detection decisions (red for absence, blue for presence) are based on the disjunctive integration rule (disjunction and negation of disjunction). Confidence decisions (dashed line for not sure, full ...

Insurers have long relied on this idea, gathering and assembling data to predict, as precisely as possible, the likelihood of ...

This valuable study presents a plastic recurrent spiking network model that spontaneously generates repeating neuronal sequences under unstructured inputs. The authors provide solid evidence that, ...

Smartphone users swipe and tap thousands of times daily. Yet, researchers have struggled to ...

Researchers developed and validated a new lung cancer prediction model, Sybil-Epi, by integrating clinical and epidemiologic data with a pre-existing model.

Canada’s S&P/TSX Small Cap Index ( TXTW-I) is up by about 90 per cent over the past 52 weeks as of Wednesday’s close. It hit ...

Polaryx Therapeutics (Nasdaq: PLYX), a clinical-stage biotechnology company focused on developing disease-modifying therapies for rare, pediatric lysosomal storage disorders (LSDs), announces that it ...

Researchers at Upgraded Points analyzed the newest IRS data available to calculate average refund amounts across states and ...

The patient was dosed at Austin Health in Melbourne, Australia, under the supervision of Professor Hui Gan. IPAX BrIGHT is assessing the safety and efficacy of TLX101-Tx in combination with ...